Tumstatin, an endothelial cell-specific inhibitor of protein synthesis
- PMID: 11778052
- DOI: 10.1126/science.1065298
Tumstatin, an endothelial cell-specific inhibitor of protein synthesis
Abstract
Tumstatin is a 28-kilodalton fragment of type IV collagen that displays both anti-angiogenic and proapoptotic activity. Here we show that tumstatin functions as an endothelial cell-specific inhibitor of protein synthesis. Through a requisite interaction with alphaVbeta3 integrin, tumstatin inhibits activation of focal adhesion kinase (FAK), phosphatidylinositol 3-kinase (PI3-kinase), protein kinase B (PKB/Akt), and mammalian target of rapamycin (mTOR), and it prevents the dissociation of eukaryotic initiation factor 4E protein (eIF4E) from 4E-binding protein 1. These results establish a role for integrins in mediating cell-specific inhibition of cap-dependent protein synthesis and suggest a potential mechanism for tumstatin's selective effects on endothelial cells.
Similar articles
-
Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins.Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4766-71. doi: 10.1073/pnas.0730882100. Epub 2003 Apr 7. Proc Natl Acad Sci U S A. 2003. PMID: 12682293 Free PMC article.
-
Vitronectin-αvβ3 integrin engagement directs hypoxia-resistant mTOR activity and sustained protein synthesis linked to invasion by breast cancer cells.Cancer Res. 2013 Jul 15;73(14):4571-8. doi: 10.1158/0008-5472.CAN-13-0218. Epub 2013 May 30. Cancer Res. 2013. PMID: 23722547
-
p53 activation results in rapid dephosphorylation of the eIF4E-binding protein 4E-BP1, inhibition of ribosomal protein S6 kinase and inhibition of translation initiation.Oncogene. 2002 Aug 8;21(34):5325-34. doi: 10.1038/sj.onc.1205662. Oncogene. 2002. PMID: 12149653
-
Insulin signaling and the control of PHAS-I phosphorylation.Prog Mol Subcell Biol. 2001;26:1-31. doi: 10.1007/978-3-642-56688-2_1. Prog Mol Subcell Biol. 2001. PMID: 11575163 Review. No abstract available.
-
Regulation of translation initiation by FRAP/mTOR.Genes Dev. 2001 Apr 1;15(7):807-26. doi: 10.1101/gad.887201. Genes Dev. 2001. PMID: 11297505 Review. No abstract available.
Cited by
-
Host microenvironment in breast cancer development: inflammatory and immune cells in tumour angiogenesis and arteriogenesis.Breast Cancer Res. 2003;5(2):83-8. doi: 10.1186/bcr573. Epub 2003 Feb 3. Breast Cancer Res. 2003. PMID: 12631386 Free PMC article. Review.
-
Angiogenesis: a curse or cure?Postgrad Med J. 2005 Apr;81(954):236-42. doi: 10.1136/pgmj.2004.023309. Postgrad Med J. 2005. PMID: 15811887 Free PMC article. Review.
-
A novel fragment derived from the beta chain of human fibrinogen, beta43-63, is a potent inhibitor of activated endothelial cells in vitro and in vivo.Br J Cancer. 2010 Feb 2;102(3):594-601. doi: 10.1038/sj.bjc.6605495. Epub 2010 Jan 12. Br J Cancer. 2010. PMID: 20068569 Free PMC article.
-
Drug resistance associated with antiangiogenesis therapy.Semin Cancer Biol. 2009 Oct;19(5):310-7. doi: 10.1016/j.semcancer.2009.05.006. Epub 2009 Jun 11. Semin Cancer Biol. 2009. PMID: 19524042 Free PMC article. Review.
-
Vasohibin-1, a negative feedback regulator of angiogenesis, ameliorates renal alterations in a mouse model of diabetic nephropathy.Diabetes. 2009 Oct;58(10):2365-75. doi: 10.2337/db08-1790. Epub 2009 Jul 8. Diabetes. 2009. PMID: 19587360 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous